Group One Trading
PDLI

Group One Trading’s PDL BioPharma, Inc. PDLI Stock Holding History

Group One Trading’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,400
Closed -$7K – 6877
2020
Q2 		$7K Sell
2,400
-2,800
-54% -$8.86K ﹤0.01% 5293
2020
Q1 		$15K Buy
+5,200
New +$16.8K ﹤0.01% 4404
2019
Q4 		– Sell
-59,200
Closed -$128K – 6005
2019
Q3 		$128K Sell
59,200
-100
-0.2% -$267 ﹤0.01% 3397
2019
Q2 		$186K Buy
59,300
+47,100
+386% +$153K ﹤0.01% 2915
2019
Q1 		$45K Buy
+12,200
New +$41.2K ﹤0.01% 3623
2018
Q4 		– Sell
-400
Closed -$1K – 5919
2018
Q3 		$1K Sell
400
-6,900
-95% -$16.9K ﹤0.01% 5116
2018
Q2 		$17K Sell
7,300
-27,700
-79% -$77.3K ﹤0.01% 4448
2018
Q1 		$103K Buy
35,000
+11,500
+49% +$31.4K ﹤0.01% 3227
2017
Q4 		$64K Sell
23,500
-3,500
-13% -$10.8K ﹤0.01% 3603
2017
Q3 		$92K Sell
27,000
-4,200
-13% -$11.7K ﹤0.01% 3298
2017
Q2 		$77K Buy
+31,200
New +$71.8K ﹤0.01% 3281
2017
Q1 		– Sell
-67,000
Closed -$142K – 5425
2016
Q4 		$142K Sell
67,000
-18,500
-22% -$51.6K ﹤0.01% 2634
2016
Q3 		$286K Buy
85,500
+78,500
+1,121% +$249K ﹤0.01% 2229
2016
Q2 		$22K Buy
7,000
+4,800
+218% +$16K ﹤0.01% 3764
2016
Q1 		$7K Buy
2,200
+1,100
+100% +$3.43K ﹤0.01% 4142
2015
Q4 		$4K Sell
1,100
-18,500
-94% -$77.4K ﹤0.01% 4450
2015
Q3 		$99K Sell
19,600
-40,500
-67% -$232K ﹤0.01% 3053
2015
Q2 		$386K Buy
60,100
+27,400
+84% +$184K 0.01% 2003
2015
Q1 		$230K Buy
32,700
+30,400
+1,322% +$220K ﹤0.01% 2268
2014
Q4 		$18K Sell
2,300
-15,200
-87% -$120K ﹤0.01% 4015
2014
Q3 		$131K Sell
17,500
-7,600
-30% -$70.6K ﹤0.01% 2762
2014
Q2 		$243K Sell
25,100
-14,300
-36% -$127K ﹤0.01% 2224
2014
Q1 		$327K Buy
39,400
+28,200
+252% +$242K 0.01% 2017
2013
Q4 		$95K Sell
11,200
-1,500
-12% -$12.6K ﹤0.01% 3091
2013
Q3 		$101K Buy
12,700
+1,900
+18% +$15.3K ﹤0.01% 3026
2013
Q2 		$83K Buy
+10,800
New +$84.2K ﹤0.01% 2990

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading's PDLI Position: Q1 2020 in Review

Group One Trading sold out of PDL BioPharma, Inc. (PDLI) in Q1 2020, closing a stake of 7,500 shares — an estimated $24.2K sold.

Group One Trading first reported a position in PDLI in Q2 2013 and held it in 18 quarters. The position peaked at $134K in Q1 2015. 133 funds tracked by Wall St. Rank hold PDLI as of Q1 2020.

  • Group One Trading reported no remaining PDL BioPharma, Inc. position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 7,500 PDL BioPharma, Inc. shares in Q1 2020, an estimated $24.2K.
  • Group One Trading first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 18 quarters.
  • Group One Trading's PDL BioPharma, Inc. position peaked at $134K in Q1 2015.
  • 133 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.